MINJUVI® (tafasitamab) for Relapsed or Refractory Follicular Lymphoma Approved in Australia

by | PRNewswire Asia

Minjuvi® (tafasitamab), in combination with rituximab and lenalidomide, is the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen to be approved in Australia for adults with relapsed or refractory follicular lymphoma...

Trinasolar Introduces Vertex N G3 Module to South Korea, Supporting High-Efficiency and Bankable Solar Deployment

by | PRNewswire Asia

SEOUL, South Korea, April 23, 2026 /PRNewswire/ — Trinasolar, a global leader in smart solar and energy storage solutions, has introduced its latest high-power module, the Vertex N G3, to the South Korea market. The module leverages Trinasolar’s...

TCL Solar Highlights Groundbreaking Solar Products at Korea Green Energy Expo 2026

by | PRNewswire Asia

Booth No: K-450 DAEGU, South Korea, April 23, 2026 /PRNewswire/ — TCL Solar is currently exhibiting its latest photovoltaic solutions at the Korea Green Energy Expo, reinforcing its commitment to advancing South Korea’s renewable energy market. As South...

THAIFEX – Anuga Asia 2026 Returns As the Industry's Business Catalyst — at a Time the F&B Sector Needs It Most

by | PRNewswire Asia

BANGKOK, April 23, 2026 /PRNewswire/ — THAIFEX – Anuga Asia returns 26–30 May 2026 at IMPACT Muang Thong Thani, Bangkok, expanded to 12 halls and 140,000+ square metres, marking its largest edition to date. The expansion comes at a time when sourcing decisions...

USANA Malaysia Launches New Vitamin D Supplement with Record-Breaking Jogging Event, Earning Malaysia Book of Records Title

by | PRNewswire Asia

KUALA LUMPUR, Malaysia, April 23, 2026 /PRNewswire/ — USANA Malaysia proudly marked a major milestone on Saturday, April 11, with the successful organization of a large-scale slow jogging event held in conjunction with the launch of its Vitamin D product. This...

Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform 'IDC224'… Driving Innovation in Subcutaneous (SC) Formulations

by | PRNewswire Asia

SEOUL, South Korea, April 23, 2026 /PRNewswire/ — Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced that it has filed a patent for ‘IDC224,’ a next-generation subcutaneous (SC) delivery platform designed...